ESOPJun 5, 2026, 04:02 PM
Spyre Therapeutics Grants 51,300 Stock Options to Four Employees
AI Summary
Spyre Therapeutics, Inc. announced that its independent Compensation Committee approved the grant of stock options for an aggregate of 51,300 shares of common stock. These equity inducement awards were granted to four non-executive employees under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan. The stock options have a 10-year term and an exercise price of $70.54 per share, vesting over a period subject to continuous service.
Key Highlights
- Spyre Therapeutics granted stock options for 51,300 shares of common stock.
- Awards were given to four non-executive employees as inducement.
- Options were granted under the 2018 Equity Inducement Plan.
- Exercise price set at $70.54 per share, based on June 1, 2026 closing price.
- Options have a 10-year term.
- Vesting schedule: 1/4th on first anniversary, then 1/48th monthly thereafter.
Price Impact
More from SYRE